Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

JSK MEDICAL : revenue, balance sheet and financial ratios

JSK MEDICAL is a French company founded 5 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in CHARENTON-LE-PONT (94220), this company of category PME shows in 2024 a net income positive of 305 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - JSK MEDICAL (SIREN 892532722)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 304 986 € 298 598 € 434 767 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, JSK MEDICAL generates positive net income of 305 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 435 k€ -> 305 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

304 986 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 76%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.408%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

76.055%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

51.2%

Solvency indicators evolution
JSK MEDICAL

Sector positioning

Debt ratio
1.41 2024
2022
2023
2024
Q1: 0.0
Med: 4.0
Q3: 41.75
Good

In 2024, the debt ratio of JSK MEDICAL (1.41) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
76.06% 2024
2022
2023
2024
Q1: 4.27%
Med: 38.89%
Q3: 76.46%
Good +11 pts over 3 years

In 2024, the financial autonomy of JSK MEDICAL (76.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 391.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

391.831

Liquidity indicators evolution
JSK MEDICAL

Sector positioning

Liquidity ratio
391.83 2024
2022
2023
2024
Q1: 138.89
Med: 313.79
Q3: 966.61
Good +11 pts over 3 years

In 2024, the liquidity ratio of JSK MEDICAL (391.83) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of JSK MEDICAL in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Based on 69 transactions of similar company sales in 2024, the value of JSK MEDICAL is estimated at 2 112 182 € (range 797 514€ - 5 287 391€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
69 tx
797k€ 2112k€ 5287k€
2 112 182 € Range: 797 514€ - 5 287 391€
NAF 5 année 2024

Valuation method used

Net Income Multiple
304 986 € × 6.9x = 2 112 183 €
Range: 797 514€ - 5 287 392€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare JSK MEDICAL with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion

Frequently asked questions about JSK MEDICAL

What is the revenue of JSK MEDICAL ?

The revenue of JSK MEDICAL is not publicly disclosed (confidential accounts filed with INPI).

Is JSK MEDICAL profitable?

Yes, JSK MEDICAL generated a net profit of 305 k€ in 2024.

Where is the headquarters of JSK MEDICAL ?

The headquarters of JSK MEDICAL is located in CHARENTON-LE-PONT (94220), in the department Val-de-Marne.

Where to find the tax return of JSK MEDICAL ?

The tax return of JSK MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does JSK MEDICAL operate?

JSK MEDICAL operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.